These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33785722)

  • 1. Prevalence of BRCA1 and BRCA2 genes promoter hypermethylation in breast cancer tissue.
    Lobanova OE; Rossokha ZI; Medvedieva NL; Cheshuk VE; Vereshchako RI; Vershyhora VO; Fishchuk LY; Zakhartseva LM; Gorovenko NG
    Exp Oncol; 2021 Mar; 43(1):56-60. PubMed ID: 33785722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLINICAL SIGNIFICANCE OF BRCA1 GENE SEQUENCING AND ITS PROMOTER METHYLATION TESTING IN THE SEARCH STRATEGY FOR THERAPEUTIC TARGETS IN BREAST CANCER TREATMENT.
    Fishchuk L; Lobanova O; Rossokha Z; Cheshuk V; Vereshchako R; Vagyn Y; Kashuba V; Vershyhora V; Popova O; Levkovich N; Zemlianska O; Ievseienkova O; Podolska S; Gorovenko N
    Exp Oncol; 2023 Oct; 45(2):161-169. PubMed ID: 37824776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Dominantly Inherited 5' UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer.
    Evans DGR; van Veen EM; Byers HJ; Wallace AJ; Ellingford JM; Beaman G; Santoyo-Lopez J; Aitman TJ; Eccles DM; Lalloo FI; Smith MJ; Newman WG
    Am J Hum Genet; 2018 Aug; 103(2):213-220. PubMed ID: 30075112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation.
    Alvarez S; Diaz-Uriarte R; Osorio A; Barroso A; Melchor L; Paz MF; Honrado E; Rodríguez R; Urioste M; Valle L; Díez O; Cigudosa JC; Dopazo J; Esteller M; Benitez J
    Clin Cancer Res; 2005 Feb; 11(3):1146-53. PubMed ID: 15709182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers.
    Kontorovich T; Cohen Y; Nir U; Friedman E
    Breast Cancer Res Treat; 2009 Jul; 116(1):195-200. PubMed ID: 18642075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene methylation in breast ductal fluid from BRCA1 and BRCA2 mutation carriers.
    Antill YC; Mitchell G; Johnson SA; Devereux L; Milner A; Di Iulio J; Lindeman GJ; Kirk J; Phillips KA; Campbell IG
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):265-74. PubMed ID: 20056647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients.
    Pirouzpanah S; Taleban FA; Mehdipour P; Atri M
    J Mol Med (Berl); 2015 Aug; 93(8):917-34. PubMed ID: 25805039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation not a frequent "second hit" in tumors with germline BRCA mutations.
    Dworkin AM; Spearman AD; Tseng SY; Sweet K; Toland AE
    Fam Cancer; 2009; 8(4):339-46. PubMed ID: 19340607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of epigenetic alteration of BRCA1 and BRCA2 genes in breast carcinomas in Tunisian patients.
    Ben Gacem R; Hachana M; Ziadi S; Amara K; Ksia F; Mokni M; Trimeche M
    Cancer Epidemiol; 2012 Apr; 36(2):190-7. PubMed ID: 21978880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA2 carriers with male breast cancer show elevated tumour methylation.
    Deb S; Gorringe KL; Pang JB; Byrne DJ; Takano EA; ; Dobrovic A; Fox SB
    BMC Cancer; 2017 Sep; 17(1):641. PubMed ID: 28893223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition.
    Dos Santos ES; Caputo SM; Castera L; Gendrot M; Briaux A; Breault M; Krieger S; Rogan PK; Mucaki EJ; Burke LJ; ; Bièche I; Houdayer C; Vaur D; Stoppa-Lyonnet D; Brown MA; Lallemand F; Rouleau E
    Breast Cancer Res Treat; 2018 Apr; 168(2):311-325. PubMed ID: 29236234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancer and early-onset sporadic breast cancer.
    Hansmann T; Pliushch G; Leubner M; Kroll P; Endt D; Gehrig A; Preisler-Adams S; Wieacker P; Haaf T
    Hum Mol Genet; 2012 Nov; 21(21):4669-79. PubMed ID: 22843497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of promoter region of BRCA1 gene versus pathogenic variants of gene: risk factor or clinical marker of breast cancer.
    Lobanova O; Medvedieva N; Fishchuk L; Dubitska O; Cheshuk V; Vereshchako R; Zakhartseva L; Rossokha Z; Gorovenko N
    Breast Cancer Res Treat; 2022 Dec; 196(3):505-515. PubMed ID: 36284026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding.
    Burke LJ; Sevcik J; Gambino G; Tudini E; Mucaki EJ; Shirley BC; Whiley P; Parsons MT; De Leeneer K; Gutiérrez-Enríquez S; Santamariña M; Caputo SM; Santana Dos Santos E; Soukupova J; Janatova M; Zemankova P; Lhotova K; Stolarova L; Borecka M; Moles-Fernández A; Manoukian S; Bonanni B; ; Edwards SL; Blok MJ; van Overeem Hansen T; Rossing M; Diez O; Vega A; Claes KBM; Goldgar DE; Rouleau E; Radice P; Peterlongo P; Rogan PK; Caligo M; Spurdle AB; Brown MA
    Hum Mutat; 2018 Dec; 39(12):2025-2039. PubMed ID: 30204945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter Hypermethylation and Expression Changes of BRCA1 Gene in a Cohort of Sporadic Breast Cancer Cases among Pakistani Population.
    Arif T; Anwar N
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2395-2401. PubMed ID: 32856871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline promoter hypermethylation in BRCA1 and BRCA2 genes is not present in hereditary breast cancer patients.
    Rodríguez-Balada M; Roig B; Melé M; Salvat M; Martorell L; Borràs J; Gumà J
    Clin Transl Oncol; 2018 Sep; 20(9):1226-1231. PubMed ID: 29404838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of Breast Cancer Predisposition Genes in Early-Onset Breast Cancer: Australian Breast Cancer Family Registry.
    Scott CM; Joo JE; O'Callaghan N; Buchanan DD; Clendenning M; Giles GG; Hopper JL; Wong EM; Southey MC
    PLoS One; 2016; 11(11):e0165436. PubMed ID: 27902704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic profiling of BRCA1/2 in ovarian tumors reveals additive diagnostic yield and evidence of a genomic BRCA1/2 DNA methylation signature.
    Aref-Eshghi E; McGee JD; Pedro VP; Kerkhof J; Stuart A; Ainsworth PJ; Lin H; Volodarsky M; McLachlin CM; Sadikovic B
    J Hum Genet; 2020 Oct; 65(10):865-873. PubMed ID: 32483276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of ATM, BRCA1, and BRCA2 promoter methylation in patients with pancreatic cancer.
    Zhou C; Porter N; Borges M; Gauthier C; Ferguson L; Huang B; Nanda N; He J; Laheru D; Hruban RH; Goggins M; Klein AP; Roberts NJ
    Pancreatology; 2021 Aug; 21(5):938-941. PubMed ID: 33839031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation.
    Brianese RC; Nakamura KDM; Almeida FGDSR; Ramalho RF; Barros BDF; Ferreira ENE; Formiga MNDC; de Andrade VP; de Lima VCC; Carraro DM
    Breast Cancer Res Treat; 2018 Feb; 167(3):803-814. PubMed ID: 29116469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.